2018 Full Year Results Media Release
Filed with ASX ·
6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
Earlier from Mayne Pharma
- Mayne Pharma acquires generic Efudex in the US
- SUBA-Itraconazole NDA accepted for review by US FDA
- Mayne Pharma opens new US manufacturing facility
- Mayne Pharma launches Amiodarone 200mg tablets in the US
- Mayne Pharmas generic NuvaRing accepted for filing by FDA
Later from Mayne Pharma
- 2018 Full Year Results Investor Presentation
- 2018 AGM Chairmans Address
- 2018 AGM CEOs Speech
- FDA approval of Tolsura (SUBA-itraconazole) capsules
- Tolsura (SUBA-itraconazole) capsule now launched in the US
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma